How many haemophiliacs in the U.K. have been treated with U.K.-source plasma-derived clotting factor concentrates (CFCs) in the critical years of 1980 to 2000?
Almost all people with haemophilia A and B were treated with U.K.-source plasma-derived clotting factor concentrates between 1980 and 2000. This is because the U.K. widely used products made in U.K. fractionation plants from U.K. plasma. That would mean that up to 6,000 people were affected. The number of 6,000 people likely includes most haemophilia A and B patients treated between 1980 and 2000, as well as a handful of other bleeding disorders treated with BPL and SNBTS products.
